Full Text
Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany

Abstract

Authors

M Augustin T Krieger D McBride CN Graham N Melzer J Kneidl K Neidhardt

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×